Studies have shown that the /IGF2BPs/PRMT7 axis, in which PRKCQ-AS1 is involved, is an ideal therapeutic target for the diagnosis and treatment of thyroid cancer [37]. This evidence concerns the gene PRKCQ and thyroid gland carcinoma.